Diagnostic and Pharmacotherapeutic Strategies for the Individualized Management of Atrial Fibrillation

Diagnostic and Pharmacotherapeutic Strategies for the Individualized Management of Atrial Fibrillation

On-Demand Webcast

Gerald V. Naccarelli, MD
Professor of Medicine
Bernard Trabin Chair of Cardiology
Penn State University School of Medicine
Chief, Division of Cardiology
Associate Clinical Director
Penn State Heart and Vascular Institute
Hershey, Pennsylvania


This activity is designed for cardiologists and cardiology-related healthcare professionals including residents, fellows, nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the care of patients with atrial fibrillation. 


After completing this activity, participants should be able to:

  • Describe the clinical and socioeconomic consequences of untreated AF, AF-related stroke, and hospitalization
  • Employ a comprehensive diagnostic strategy, including assessment of stroke and bleeding risk, for patients with AF
  • Determine the risk/benefit profiles of available AADs for a given patient based on efficacy, safety, and patient-specific characteristics
  • Evaluate the available clinical data surrounding favorable AAD/anticoagulant combination strategies for the treatment of AF and prevention of AF-related stroke
  • Develop individualized AF management strategies that incorporate rate, rhythm, anticoagulation, and/or ablation therapies as appropriate

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

ACPE Credit Policy

Your official record of ACPE credit will be generated through the CPE Monitor System. The certificate printed from this website after completing the evaluation for this activity is for personal tracking purposes only.

Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. Please note that you must complete the activity evaluation within 60 days of a live activity or within 60 days of beginning the evaluation for an enduring activity. Under ACPE Policy, NACCME will not be able to report your activity completion to CPE Monitor after this 60-day period.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring webcast.

Release Date: September 27, 2018
Expiration Date: September 27, 2019
Estimated time to complete: 1 hour

The is no fee associated with this activity. 

For questions regarding this educational-activity, please call 609-371-1137.


Participants are requested to complete the evaluation immediately following the educational session and return the completed survey to a NACCME representative. 

All individuals who participated in the activity must complete and submit the evaluation form -- to the onsite representative or by mail or fax within 2 weeks after the date of the activity -- to receive documentation of credit. Documentation of credit will be received within 8 weeks. 


  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


NACCME designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in each activity. 

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. 


This continuing nursing education activity awards 1.0 contact hour. 

Provider approved by the California Board of Registered Nursing. Provider #13255 for 1.0 contact hour. 

Nursing practitioners participating in this educational activity will earn an AMA PRA Category 1 Credit™ certificate of completion for ANCC contact hours through AANP's reciprocity agrements. 


This enduring activity is approved for 1.0 contact hour (0.1 CEU) of continuing pharmacy education (UAN JA0006201-0000-18-199-H01-P).

This educational activity is a knowledge-based activity.

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager, Accreditation & Compliance, NACCME, in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Senior Manage, Accreditation & Compliance will review the grievance and respond within 30 days of receiving the written statement. if the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.


The planning committee comprises Gerald V. Naccarelli, MD; Amy Ghiretti, Jennifer Ilcyn, Mary Johnson, Todd Kunkler, Randy Robbin, Margaret Stefan, and Susan Yarbrough, NACCME. 

Independent clinical reviewer: Peter Oettgen, MD, Associate Professor of Medicine, Harvard Medical School, Director of Preventive Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Nurse planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California


According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty have reported the following:

Dr. Naccarelli: Advisory Board – Janssen; Consultant – Acesion, Glaxo-Smith-Kline, Janssen, Novartis, Omeicos, Portola, Sanofi; Research – Janssen

Ms. Seaman: Advisory Board - Mölnlycke

Ms. Ghiretti, Ms. Ilcyn, Ms. Johnson, Mr. Kunkler, Mr. Robbin, Ms. Stefan, and Ms. Yarbrough have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed.


North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.


Supported by an educational grant from Sanofi US.


NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.